Business Wire

Red Sea Global Unveils Nammos Resort AMAALA, Introducing Nammos’ First Resort Hotel Globally

8.9.2026 11:59:00 EEST | Business Wire | Press release

Share

Red Sea Global (RSG), the regenerative tourism developer, today announced the opening of Nammos Resort AMAALA, marking the launch of Nammos’ first resort hotel globally and a significant addition to AMAALA’s growing lifestyle and hospitality offering.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908621917/en/

A marvellous view of the night sky from inside the resort hotel

Set along the shores of Triple Bay with sweeping views across the Red Sea and Dumega Bay and designed around Nammos’ philosophy of Endless Joy, Nammos Resort AMAALA introduces the brand’s distinctive blend of Mediterranean sophistication and vibrant social energy to one of the world’s most comprehensive wellness destinations.

“Nammos Resort AMAALA strengthens the diversity of experiences available across the destination bringing the unmistakable energy and spirit of Mykonos to the Saudi Red Sea coast. As AMAALA continues to expand with each new opening, the addition of Nammos reinforces our ambition to establish one of the world's leading luxury lifestyle and wellness destinations,” said Group CEO John Pagano.

Designed by the renowned architectural firm Foster + Partners, the resort features 110 keys and 20 private residences, seamlessly integrating contemporary luxury with the natural beauty of the destination. Inspired by the timeless character of the Cyclades and the rich heritage of Saudi Arabia’s coastline, each stay has been thoughtfully designed to create a sense of privacy, comfort and effortless luxury.

The resort's signature Nammos Beach Club occupies its own private island, accessible via an exclusive boardwalk or private jetty. It delivers the vibrant atmosphere for which Nammos is internationally known, complemented by panoramic sea views and Mediterranean-inspired cuisine.

Carolyn Turnbull, CEO of Nammos Hotels & Resorts, said: "Today is much more than the opening of a hotel. It is the beginning of an entirely new chapter for Nammos. We have taken everything people know and love about the brand – its sense of occasion, exceptional hospitality, unforgettable dining and distinctive energy – and reimagined it as a complete resort experience. There is nowhere else in the world where Nammos could have made this leap quite like AMAALA, and we are incredibly proud to welcome our very first guests."

Complementing the resort’s hospitality offering is the debut of Nammos Spa, home to Boundless Wellbeing, a wellness destination designed for both social connection and personal renewal, where wellbeing is seamlessly integrated into every aspect of the Nammos lifestyle. Trademark experiences include late-night sound healing, soundscape beats, spa parties, radical manifestation sessions, and advanced skin health experiences combining wellbeing with the brand's distinctive social energy.

Beyond the resort, guests have access to a rich program of experiences across AMAALA, from marine adventures and sailing excursions to wellness trails, equestrian experiences, and destination celebrations set against the backdrop of the Red Sea coastline.

For younger guests, the Blu Kids Club offers a dedicated space for discovery, creativity and nature-inspired learning, ensuring memorable experiences for families travelling together.

Nammos Residences AMAALA presents an exclusive collection of 20 private residences overlooking a vibrant waterfront marina, where the effortless elegance of Mykonian hospitality meets the natural beauty of the Red Sea. The collection comprises one, two and three-bedroom apartments, alongside an exceptional three-bedroom penthouse, each thoughtfully designed with spacious interiors, expansive terraces and panoramic sea and marina views. Managed by Nammos Hotels & Resorts, the residences offer homeowners privileged access to world-class dining, the iconic Nammos Beach Club, resort amenities and personalized services. Blending sophisticated coastal living with a vibrant social atmosphere, Nammos Residences AMAALA offers a rare opportunity to own a home in one of the Red Sea's most exclusive waterfront destinations.

Nammos is the sixth resort to open at AMAALA. In the coming months a further three resorts will open, alongside more branded residences, wellness facilities, marinas, retail, and dining offerings.

About Red Sea Global

Red Sea Global (RSG) is a vertically integrated real estate developer with a diverse portfolio across tourism, residential, experiences, infrastructure, transport, healthcare, and services. This includes the luxury regenerative tourism destinations The Red Sea, which began welcoming guests in 2023, and AMAALA, which welcomed its first guests in 2026.

A third destination, Thuwal Private Retreat, opened in 2024. RSG was also entrusted with development works at AlWajh International Airport, focused on upgrading the terminal and infrastructure.

RSG is a PIF company and a cornerstone of Saudi Arabia’s ambition to diversify its economy. Across its growing portfolio of destinations, subsidiaries, and businesses, RSG seeks to lead the world toward a more sustainable future, showing how responsible development can uplift communities, drive economies, and enhance the environment.

About AMAALA

AMAALA is an unparalleled ultra-luxury wellness destination along the northwestern coast of the Red Sea in Saudi Arabia. Seamlessly blending sea, sun, sports, arts, and culture for an exceptional experience, it is one of the world’s most anticipated destinations developed by Red Sea Global (RSG) with regeneration at its core.

AMAALA officially opened its first resort in summer of 2026, with more than 1,600 hotel rooms set to open across nine different resorts complemented by high-end retail and fine dining experiences upon completion. The destination’s state-of-the-art wellness and spa facilities will offer a comprehensive array of multi-generational programs, services, and various therapies, customized by practitioners and cetners pioneering in various medical and wellness fields for a more personalized wellness journey.

Influenced by AMAALA’s natural beauty and the purity of the Red Sea, the destination is where sustainability meets luxury. The aim of AMAALA is to offer the most comprehensive health and wellness experience that will help improve the wellbeing of its guests and community, helping them flourish and thrive.

Two of AMAALA’s hallmark features include Corallium Marine Life Institute, an educational and scientific research center, and the AMAALA Yacht Club, destined to become an international hub for luxury yachting.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260908621917/en/

Contacts

For more information, please contact:
Arwa Alsantli, Manager - Public Relations
+966 56 616 6017
Arwa.Alsantli@RedSeaGlobal.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo ® ) in Patients With Mycosis Fungoides and Sézary Syndrome12.10.2026 09:00:00 EEST | Press release

Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and add to the growing body of evidence supporting its use in routine clinical practice.1-3 Conducted as a company-sponsored, multicentric, non-interventional, combined retro-prospective real-world study across 18 centres throughout Germany, MINT brought together cutaneous T‑cell lymphoma (CTCL) specialists to evaluate treatment outcomes with mogamulizumab in a real-world setting, with time-to-next-treatment (TTNT) as the study’s primary endpoint.1 The study captured a broad and heterog

Megaport Expands Global Automated Infrastructure Platform Into Portugal12.10.2026 09:00:00 EEST | Press release

Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of its services in Portugal, expanding its European footprint and enabling enterprises and service providers in the region to connect instantly to the world’s leading cloud, network, and data center providers. With new on-ramps in Lisbon, customers in Portugal can now access Megaport’s automated infrastructure platform as well as more than 1,200 enabled data centers worldwide. This launch gives enterprises, MSPs, and carriers private, high-performance compute, network, and storage, as well as on-demand regional interconnection with scalable bandwidth. With Portugal’s data center market projected to reach US$3.09 billion by 2030 as well as Lisbon’s proximity to major submarine cable landings, the strengthening global connectivity hub is a natural next step for Megaport. “Portugal’s digital economy is rapidly growing, and infrastructure is at the heart of that transfor

Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 19:09:00 EEST | Press release

Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,

Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 13:30:00 EEST | Press release

As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 20:15:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye